View our Market Insights webinar that features an enlightening exploration of the intersection between mental health and rare diseases.
JMCP: Implementing Continuous Glucose Monitoring to Improve Patient Outcomes in Diabetes
PUBLISHED IN JMCP | January, 2024
Summary
Diabetes technology is the hardware, devices, and software that people with diabetes use to help manage their condition. Diabetes technology has expanded to include complex devices that both monitor blood sugar and deliver insulin. The American Diabetes Association now recommends use of continuous glucose monitoring (CGM) in individuals with both type 1 and type 2 diabetes. Rapid change in the diabetes technology landscape may lead to access barriers that can impact health plan programs, necessitating appropriate coverage policies.
For more disease state research, view the Market Insights Program.
Related
Stay ahead of industry shifts with insights from the AMCP Foundation’s Emerging Trends Initiative. Published in JMCP, this report explores key developments in technology, therapeutics, payment models, pharmacy operations, and policy. Learn how these trends impact managed care pharmacy professionals and what they mean for you and your business.
Read the Journal of Managed Care + Specialty Pharmacy (JMCP) February 2025 Issue
Featured News & Resources
See Full CalendarUpcoming Events
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
